Different routes of CNS-directed therapies in MCL. Among patients with MCL, the average survival following development of CNS involvement is typically <6 months, despite treatment with intravenous and intrathecal chemotherapy. Bernard et al describe 3 cases of CNS MCL with ongoing remissions at 2 months, 9 months, and 1 year. Professional illustration by Patrick Lane, ScEYEnce Studios.